Originally published on Best Stocks Category: best stocks to buy nowOn Monday, October 3, SVP John D. Couling of Dolby Laboratories, Inc. (NYSE: DLB) sold 50,000 shares. At an average price of $66.02, the stock was sold for a total transaction value of $3,301,000.00. After the acquisition, the senior vice president owns 79,235 company shares worth $5,231,094.70. You can access a file given to the Securities and Exchange Commission that describes the sale by clicking on this link. Deposit $100 and get a $110 to trade stocks>>>>>>>>>>Open Account On Tuesday, August 9, Dolby Laboratories (NYSE: DLB) released its most recent earnings report. The electronics manufacturer earned $0.42 EPS for the quarter, which was $0.05 over analysts’ forecasts. Dolby Laboratories had a return on equity of 9.38% and a net margin of 15.91%. In contrast to the average estimate of $294.03 million, the company’s sales for the quarter came in at $289.60 million. During the same quarter the previous year, the company generated $0.52 in profit per share. Compared to the same quarter the previous year, revenue for the quarter increased by 1.0%. Equity research analysts predict that Dolby Laboratories, Inc. is expected to report 2.36 EPS for the current fiscal year, predict equity research analysts.The business also declared a quarterly dividend, which was paid on August 31. On Tuesday, August 23, investors of record received a $0.25 dividend. The ex-dividend date for this dividend was August 22, a Monday. This results in a $1 dividend with a 1.47% annual yield. Dolby Laboratories’ current dividend payout ratio is 51.55%. Following a $0.21 loss on Wednesday, NYSE: DLB traded for $68.16. The company’s stock experienced trading activity of 288,171 shares versus its average volume of 499,747 shares. Dolby Laboratories, Inc.’s low and high prices over the previous twelve months were $64.64 and $96.85, respectively. The company is an excellent investment with a market value of $6.88 billion, a price-to-earnings ratio of 35.13, an earnings-growth ratio of 1.51, and a beta of 0.99. Currently, the stock is trading between its 50-day and 200-day moving averages, $74.93. Institutional and hedge fund interest in the company has lately increased or dropped. Wolverine Trading LLC grew its stake in Dolby Laboratories during the fourth quarter by $277,000. LPL Financial LLC grew its stake in Dolby Laboratories by 33.7% during the fourth quarter. After acquiring an additional 13,866 shares in the most recent quarter, LPL Financial LLC now owns 54,966 shares of the $5,234,000 market cap business. D. E. Shaw & Co., Inc. grew its stake in Dolby Laboratories by 1,499.5% in the fourth quarter. D. E. Shaw & Co., Inc. now owns 117,103 shares of the electronics maker’s stock valued at $11,151,000 following the purchase of an additional 109,782 shares in the most recent quarter. Mackenzie Financial Corp. boosted its stake in Dolby Laboratories by 15.3% in the fourth quarter. After acquiring an extra 219,914 shares in the most recent quarter, Mackenzie Financial Corp currently holds shares in the electronics industry worth $157,737,00. Finally, Laurel Wealth Advisors Inc. purchased a new $1,431,000 holding in Dolby Laboratories shares during the fourth quarter. Institutional investors and hedge funds hold 59.13% of the firm’s stock. Several equity analysts have recently provided the business with remarks. In a research note published on Tuesday, August 9, StockNews.com changed its rating for Dolby Laboratories from “hold” to “buy.” In addition, TheStreet downgraded Dolby Laboratories from “b-” to “c+” in a report released on Friday, July 1. The company has an average price target of $90.00 and a widespread consensus rating of “Buy,” according to data from Bloomberg.com. Four research analysts have awarded the stock ratings.